Bailard, Inc. Lantheus Holdings, Inc. Transaction History

Bailard, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	SELL	$82.41 - $99.65 $82,410 - $99,650	-1,000 Reduced 12.2%	7,200 $604,000
Q1 2023 May 08, 2023	BUY	$47.76 - $82.86 $52,536 - $91,146	1,100 Added 15.49%	8,200 $676,000
Q4 2022 Feb 02, 2023	BUY	$48.76 - $77.67 $346,196 - $551,457	7,100 New	7,100 $361,000

539

69.9M

651K

459K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.63B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.